Michael D. Wendt§Protein-Protein Interactions as Drug Targets§§Shaomeng Wang , Yujun Zhao , Denzil Bernard , Angelo Aguilar , Sanjeev Kumar§Targeting the MDM2-p53 Protein-Protein Interaction for New Cancer Therapeutics§§Kurt Deshayes , Jeremy Murray , Domagoj Vucic§The Development of Small-Molecule IAP Antagonists for the Treatment of Cancer §§John F. Kadow , David R. Langley , Nicholas A. Meanwell , Michael A. Walker , Kap-Sun Yeung , Richard Pracitto§Protein-Protein Interaction Targets to Inhibit HIV-1 Infection§§Nicholas A. Meanwell , David R. Langley§Inhibitors of Protein-Protein Interactions in Paramyxovirus Fusion a Focus on Respiratory Syncytial Virus§§Andrew B. Mahon , Stephen E. Miller , Stephen T. Joy , Paramjit S. Arora§Rational Design Strategies for Developing Synthetic Inhibitors of Helical Protein Interfaces§§Michael D. Wendt§The Discovery of Navitoclax, a Bcl-2 Family Inhibitor§§